PP
ETRM

Paloma Partners’s EnteroMedics Inc. ETRM Stock Holding History

Paloma Partners’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-27
Closed -$40K – 1647
2014
Q4 		$40K Buy
+27
New +$36.5K ﹤0.01% 1101
2013
Q3 		– Sell
-148
Closed -$177K – 1479
2013
Q2 		$177K Buy
+148
New +$156K 0.01% 959

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCCM
Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return

Paloma Partners's ETRM Position: Q1 2015 in Review

Paloma Partners sold out of EnteroMedics Inc. (ETRM) in Q1 2015, closing a stake of 27 shares — an estimated $40K sold.

Paloma Partners first reported a position in ETRM in Q2 2013 and held it in 2 quarters. The position peaked at $177K in Q2 2013. 51 funds tracked by Wall St. Rank hold ETRM as of Q1 2015.

  • Paloma Partners reported no remaining EnteroMedics Inc. position as of Q1 2015 after selling out during the quarter.
  • Paloma Partners sold 27 EnteroMedics Inc. shares in Q1 2015, an estimated $40K.
  • Paloma Partners first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 2 quarters.
  • Paloma Partners's EnteroMedics Inc. position peaked at $177K in Q2 2013.
  • 51 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2015.

Based on Paloma Partners's 13F filing for Q1 2015, filed 15 May 2015.